FI943422A - Menetelmä sytolyyttisen T-solujen prekursorien määrittämiseksi - Google Patents

Menetelmä sytolyyttisen T-solujen prekursorien määrittämiseksi Download PDF

Info

Publication number
FI943422A
FI943422A FI943422A FI943422A FI943422A FI 943422 A FI943422 A FI 943422A FI 943422 A FI943422 A FI 943422A FI 943422 A FI943422 A FI 943422A FI 943422 A FI943422 A FI 943422A
Authority
FI
Finland
Prior art keywords
cytolytic
precursors
cells
determining
determining precursors
Prior art date
Application number
FI943422A
Other languages
English (en)
Swedish (sv)
Other versions
FI943422A0 (fi
Inventor
Pierre G Coulie
Thierry Boon-Falleur
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of FI943422A publication Critical patent/FI943422A/fi
Publication of FI943422A0 publication Critical patent/FI943422A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0636T lymphocytes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI943422A 1992-01-21 1994-07-19 Menetelmä sytolyyttisen T-solujen prekursorien määrittämiseksi FI943422A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82393392A 1992-01-21 1992-01-21
PCT/US1993/000083 WO1993014189A1 (en) 1992-01-21 1993-01-07 Method for determining cytolytic t cell precursors

Publications (2)

Publication Number Publication Date
FI943422A true FI943422A (fi) 1994-07-19
FI943422A0 FI943422A0 (fi) 1994-07-19

Family

ID=25240169

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943422A FI943422A0 (fi) 1992-01-21 1994-07-19 Menetelmä sytolyyttisen T-solujen prekursorien määrittämiseksi

Country Status (8)

Country Link
EP (1) EP0624189A4 (fi)
JP (1) JPH07503134A (fi)
KR (1) KR950700402A (fi)
AU (1) AU3435293A (fi)
CA (1) CA2128424A1 (fi)
FI (1) FI943422A0 (fi)
NO (1) NO942660L (fi)
WO (1) WO1993014189A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU664560B2 (en) * 1991-05-23 1995-11-23 Ludwig Institute For Cancer Research Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
US6280962B1 (en) 1991-11-25 2001-08-28 Yoreh Biotechnologies Ltd. Whole blood/mitogen assay for the early detection of a subject with cancer and kit
US6322989B1 (en) 1991-11-25 2001-11-27 Yoreh Biotechnologies, Ltd. Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
US6352826B1 (en) 1991-11-25 2002-03-05 Yoreh Biotechnologies, Ltd. Method and kit for the detection of retroviral specific antibodies in seronegative individuals
US5874560A (en) 1994-04-22 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Melanoma antigens and their use in diagnostic and therapeutic methods
WO1995029193A2 (en) 1994-04-22 1995-11-02 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services Melanoma antigens
US5843648A (en) * 1995-01-10 1998-12-01 The United States Of America As Represented By The Secretary, Department Of Health And Human Services P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
US6951917B1 (en) 1995-09-26 2005-10-04 The United States Of America As Represented By The Department Of Health And Human Services MHC-class II restricted melanoma antigens and their use in therapeutic methods
US7501501B2 (en) 1995-09-26 2009-03-10 The United States Of America As Represented By The Secretary Department Of Health And Human Services MHC-Class II restricted melanoma antigens and their use in therapeutic methods
ATE244300T1 (de) * 1996-01-17 2003-07-15 Imp College Innovations Ltd Immunotherapie mit verwendung von zytotoxischen t lymphozyten (ctl)
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
CA2272924A1 (en) * 1996-11-22 1998-05-28 Shiloov Medical Technologies Ltd. A whole blood/mitogen assay for the early detection of a subject with cancer and kit

Also Published As

Publication number Publication date
JPH07503134A (ja) 1995-04-06
AU3435293A (en) 1993-08-03
WO1993014189A1 (en) 1993-07-22
EP0624189A1 (en) 1994-11-17
EP0624189A4 (en) 1995-05-17
CA2128424A1 (en) 1993-07-22
NO942660L (no) 1994-09-16
KR950700402A (ko) 1995-01-16
FI943422A0 (fi) 1994-07-19
NO942660D0 (no) 1994-07-15

Similar Documents

Publication Publication Date Title
DE69115991D1 (de) Förderbandsystem
FI923931A (fi) Anordning foer granskning av insidan av en foergrenad roerlinje
FI945742A0 (fi) Järjestelmäkehityksen tuki
DE69125510T2 (de) Offline Schnittsysteme
FI945610A (fi) Laitteisto ohutkalvojen valmistamiseksi
FI933268A (fi) System foer bestrykning av papper och kartong
DE69308230T2 (de) Fördersystem
FI943422A (fi) Menetelmä sytolyyttisen T-solujen prekursorien määrittämiseksi
FI931121A (fi) Bockningspress foer framstaellning av boejda glasrutor
NO176415C (no) Lyslist for nivåglass
FI904845A0 (fi) Kuvausmenetelmä kappaleiden rakenteen määrittämiseksi
FI945946A (fi) Menetelmä fosforin poistamiseksi
ITMI930193A0 (it) Sincronizzatore per innesti
FI923866A (fi) Foerfarande foer framstaellning av 1-hydroxialkyl-1-nitro-5 imidazoler
FI930710A0 (fi) Anordning foer oevervakning av vaetskenivao
FI943660A (fi) Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi
FI921817A (fi) Foerfarande och system foer aotergivning av audiofrekvenser
FI951441A0 (fi) Menetelmä 5-formyyliamino-pyrimidiinien valmistamiseksi
FI953181A0 (fi) Puriinien valmistusmenetelmä
FI923005A0 (fi) Putken kannatin
FI934756A0 (fi) Anordning foer avlaegsnande av utstansade delar
FI950381A0 (fi) Esteröintimenetelmä
DE59307840D1 (de) Phosphinigsäure-arylester
ITBO920282A1 (it) Metodo per la realizzazione di sigarette con filtro
FI91026C (fi) Parannettu menetelmä taskien käsittelemiseksi

Legal Events

Date Code Title Description
FD Application lapsed